{"id":"https://openalex.org/W2129104200","doi":"https://doi.org/10.1002/ajh.23831","title":"Flow cytometry detection of minimal residual disease in multiple myeloma: Lessons learned at FDA\u2010NCI roundtable symposium","display_name":"Flow cytometry detection of minimal residual disease in multiple myeloma: Lessons learned at FDA\u2010NCI roundtable symposium","publication_year":2014,"publication_date":"2014-08-16","ids":{"openalex":"https://openalex.org/W2129104200","doi":"https://doi.org/10.1002/ajh.23831","mag":"2129104200","pmid":"https://pubmed.ncbi.nlm.nih.gov/25132630"},"language":"en","primary_location":{"id":"doi:10.1002/ajh.23831","doi":"https://doi.org/10.1002/ajh.23831","is_oa":false,"landing_page_url":"https://doi.org/10.1002/ajh.23831","pdf_url":null,"source":{"id":"https://openalex.org/S199810014","display_name":"American Journal of Hematology","issn_l":"0361-8609","issn":["0361-8609","1096-8652"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-1","poland-140","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Journal of Hematology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5082004555","display_name":"Ola Landgren","orcid":"https://orcid.org/0000-0001-6485-4839","observed_orcids":["https://orcid.org/0000-0001-6485-4839"]},"institutions":[{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Ola Landgren","raw_affiliation_strings":["National Cancer Institute (NCI), Bethesda, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Cancer Institute (NCI), Bethesda, Maryland","institution_ids":["https://openalex.org/I4210140884"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047911909","display_name":"Nicole J. Gormley","orcid":"https://orcid.org/0000-0001-6379-5101","observed_orcids":["https://orcid.org/0000-0001-6379-5101"]},"institutions":[{"id":"https://openalex.org/I1320320070","display_name":"United States Food and Drug Administration","ror":"https://ror.org/034xvzb47","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nicole Gormley","raw_affiliation_strings":["U.S. Food and Drug Administration (FDA), Silver Spring, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"U.S. Food and Drug Administration (FDA), Silver Spring, Maryland","institution_ids":["https://openalex.org/I1320320070"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010626626","display_name":"Danielle M. Turley","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1320320070","display_name":"United States Food and Drug Administration","ror":"https://ror.org/034xvzb47","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Danielle Turley","raw_affiliation_strings":["U.S. Food and Drug Administration (FDA), Silver Spring, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"U.S. Food and Drug Administration (FDA), Silver Spring, Maryland","institution_ids":["https://openalex.org/I1320320070"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063301766","display_name":"Roger G. Owen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801331674","display_name":"St James's University Hospital","ror":"https://ror.org/013s89d74","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2799390153","https://openalex.org/I2801331674"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Roger G. Owen","raw_affiliation_strings":["HMDS Laboratory, St James's Institute of Oncology, Leeds, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"HMDS Laboratory, St James's Institute of Oncology, Leeds, United Kingdom","institution_ids":["https://openalex.org/I2801331674"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001511648","display_name":"Andy C. Rawstron","orcid":"https://orcid.org/0000-0003-0798-9790","observed_orcids":["https://orcid.org/0000-0003-0798-9790"]},"institutions":[{"id":"https://openalex.org/I2801331674","display_name":"St James's University Hospital","ror":"https://ror.org/013s89d74","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2799390153","https://openalex.org/I2801331674"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Andy Rawstron","raw_affiliation_strings":["HMDS Laboratory, St James's Institute of Oncology, Leeds, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"HMDS Laboratory, St James's Institute of Oncology, Leeds, United Kingdom","institution_ids":["https://openalex.org/I2801331674"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057189669","display_name":"Bruno Paiva","orcid":"https://orcid.org/0000-0003-1977-3815","observed_orcids":["https://orcid.org/0000-0003-1977-3815","https://orcid.org/0000-0002-0128-8849"]},"institutions":[{"id":"https://openalex.org/I4210135003","display_name":"Clinica Universidad de Navarra","ror":"https://ror.org/03phm3r45","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210135003"]},{"id":"https://openalex.org/I4392738196","display_name":"Centro de Investigaci\u00f3n M\u00e9dica Aplicada","ror":"https://ror.org/01qew8q20","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I4392738196","https://openalex.org/I88155538"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Bruno Paiva","raw_affiliation_strings":["Cl\u00ednica Universidad de Navarra; Centro de Investigaci\u00f3n M\u00e9dica Aplicada (CIMA) Pamplona Spain; on behalf of the Spanish Myeloma Group (PETHEMA/GEM)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cl\u00ednica Universidad de Navarra; Centro de Investigaci\u00f3n M\u00e9dica Aplicada (CIMA) Pamplona Spain; on behalf of the Spanish Myeloma Group (PETHEMA/GEM)","institution_ids":["https://openalex.org/I4210135003","https://openalex.org/I4392738196"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080669957","display_name":"David B. Barnett","orcid":"https://orcid.org/0000-0002-7658-5856","observed_orcids":["https://orcid.org/0000-0002-7658-5856"]},"institutions":[{"id":"https://openalex.org/I2801732343","display_name":"Royal Hallamshire Hospital","ror":"https://ror.org/00514rc81","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2801732343","https://openalex.org/I4210102902"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"David Barnett","raw_affiliation_strings":["UK NEQAS for Leucocyte Immunophenotyping, Royal Hallamshire Hospital, Shefield, England"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UK NEQAS for Leucocyte Immunophenotyping, Royal Hallamshire Hospital, Shefield, England","institution_ids":["https://openalex.org/I2801732343"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053110335","display_name":"Maria Jorge Arroz","orcid":"https://orcid.org/0000-0002-7648-3294","observed_orcids":["https://orcid.org/0000-0002-7648-3294"]},"institutions":[{"id":"https://openalex.org/I4210106487","display_name":"Hospital de Egas Moniz","ror":"https://ror.org/012habm93","country_code":"PT","type":"healthcare","lineage":["https://openalex.org/I4210106487"]},{"id":"https://openalex.org/I4210122709","display_name":"Hospital de Santa Cruz","ror":"https://ror.org/02r581p42","country_code":"PT","type":"healthcare","lineage":["https://openalex.org/I4210122709"]},{"id":"https://openalex.org/I4210124394","display_name":"Centro Hospitalar de Lisboa Ocidental","ror":"https://ror.org/036ypft38","country_code":"PT","type":"healthcare","lineage":["https://openalex.org/I4210124394"]},{"id":"https://openalex.org/I4210136214","display_name":"Hospital of St. Francis Xavier","ror":"https://ror.org/03qxkp346","country_code":"PT","type":"healthcare","lineage":["https://openalex.org/I4210136214"]}],"countries":["PT"],"is_corresponding":false,"raw_author_name":"Maria Arroz","raw_affiliation_strings":["Centro Hospitalar de Lisboa Ocidental (CHLO), HSFX, Clinical Pathology Department, Lisbon, Portugal"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centro Hospitalar de Lisboa Ocidental (CHLO), HSFX, Clinical Pathology Department, Lisbon, Portugal","institution_ids":["https://openalex.org/I4210106487","https://openalex.org/I4210122709","https://openalex.org/I4210124394","https://openalex.org/I4210136214"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065404552","display_name":"Paul K. Wallace","orcid":"https://orcid.org/0000-0001-7823-9917","observed_orcids":["https://orcid.org/0000-0001-7823-9917"]},"institutions":[{"id":"https://openalex.org/I1292894508","display_name":"Roswell Park Comprehensive Cancer Center","ror":"https://ror.org/0499dwk57","country_code":"US","type":"facility","lineage":["https://openalex.org/I1292894508"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Paul Wallace","raw_affiliation_strings":["Roswell Park Cancer Institute, Department of Flow and Image Cytometry, Buffalo, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Roswell Park Cancer Institute, Department of Flow and Image Cytometry, Buffalo, New York","institution_ids":["https://openalex.org/I1292894508"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026109406","display_name":"Brian G.M. Durie","orcid":"https://orcid.org/0000-0002-9883-3769","observed_orcids":["https://orcid.org/0000-0002-9883-3769"]},"institutions":[{"id":"https://openalex.org/I1282927834","display_name":"Cedars-Sinai Medical Center","ror":"https://ror.org/02pammg90","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1282927834"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brian Durie","raw_affiliation_strings":["Cedars-Sinai Comprehensive Cancer Center, Los Angeles, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cedars-Sinai Comprehensive Cancer Center, Los Angeles, California","institution_ids":["https://openalex.org/I1282927834"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014636271","display_name":"Constance M. Yuan","orcid":"https://orcid.org/0000-0002-2601-3665","observed_orcids":["https://orcid.org/0000-0002-2601-3665"]},"institutions":[{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Constance Yuan","raw_affiliation_strings":["National Cancer Institute (NCI), Bethesda, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Cancer Institute (NCI), Bethesda, Maryland","institution_ids":["https://openalex.org/I4210140884"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024505450","display_name":"Ahmet Do\u01e7an","orcid":"https://orcid.org/0000-0001-6576-5256","observed_orcids":["https://orcid.org/0000-0001-6576-5256","https://orcid.org/0000-0003-1818-9764"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ahmet Dogan","raw_affiliation_strings":["Hematopathology Service, Memorial Sloan-Kettering Cancer Center, New York, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematopathology Service, Memorial Sloan-Kettering Cancer Center, New York, New York","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065696086","display_name":"Maryalice Stetler\u2010Stevenson","orcid":"https://orcid.org/0000-0003-2591-0353","observed_orcids":["https://orcid.org/0000-0003-2591-0353"]},"institutions":[{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Maryalice Stetler\u2010Stevenson","raw_affiliation_strings":["National Cancer Institute (NCI), Bethesda, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Cancer Institute (NCI), Bethesda, Maryland","institution_ids":["https://openalex.org/I4210140884"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5113663500","display_name":"Gerald E. Marti","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1320320070","display_name":"United States Food and Drug Administration","ror":"https://ror.org/034xvzb47","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gerald E. Marti","raw_affiliation_strings":["U.S. Food and Drug Administration (FDA), Silver Spring, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"U.S. Food and Drug Administration (FDA), Silver Spring, Maryland","institution_ids":["https://openalex.org/I1320320070"]}]}],"institutions":[],"countries_distinct_count":4,"institutions_distinct_count":13,"corresponding_author_ids":["https://openalex.org/A5082004555"],"corresponding_institution_ids":["https://openalex.org/I4210140884"],"apc_list":{"value":5450,"currency":"USD","value_usd":5450},"apc_paid":null,"fwci":8.5123,"has_fulltext":false,"cited_by_count":56,"citation_normalized_percentile":{"value":0.98091735,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":100},"biblio":{"volume":"89","issue":"12","first_page":"1159","last_page":"1160"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11235","display_name":"Statistical Methods in Clinical Trials","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/multiple-myeloma","display_name":"multiple myeloma","score":0.8600000143051147},{"id":"https://openalex.org/keywords/measurable-residual-disease","display_name":"minimal residual disease","score":0.9980000257492065},{"id":"https://openalex.org/keywords/flow-cytometry","display_name":"flow cytometry","score":0.8510000109672546},{"id":"https://openalex.org/keywords/drug-approval","display_name":"drug approval","score":0.6919999718666077},{"id":"https://openalex.org/keywords/regulatory-qualification","display_name":"regulatory qualification","score":0.3319999873638153},{"id":"https://openalex.org/keywords/stringent-complete-response","display_name":"stringent complete response","score":0.6209999918937683},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.906000018119812},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.6420000195503235},{"id":"https://openalex.org/keywords/molecular-assays","display_name":"molecular assays","score":0.5080000162124634},{"id":"https://openalex.org/keywords/confounding-factors","display_name":"confounding factors","score":0.7009999752044678},{"id":"https://openalex.org/keywords/drug-response-prediction","display_name":"drug response prediction","score":0.4569999873638153},{"id":"https://openalex.org/keywords/bone-marrow-aspirate","display_name":"bone marrow aspirate","score":0.5649999976158142},{"id":"https://openalex.org/keywords/molecular-imaging","display_name":"molecular imaging","score":0.7870000004768372},{"id":"https://openalex.org/keywords/high-dose-therapy","display_name":"high-dose therapy","score":0.5270000100135803}],"concepts":[{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.755662202835083},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7522244453430176},{"id":"https://openalex.org/C2781197716","wikidata":"https://www.wikidata.org/wiki/Q864574","display_name":"Biomarker","level":2,"score":0.7498494982719421},{"id":"https://openalex.org/C141341695","wikidata":"https://www.wikidata.org/wiki/Q2368661","display_name":"Surrogate endpoint","level":2,"score":0.6732369661331177},{"id":"https://openalex.org/C2779823535","wikidata":"https://www.wikidata.org/wiki/Q6865356","display_name":"Minimal residual disease","level":3,"score":0.5866366028785706},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.5791144967079163},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5093003511428833},{"id":"https://openalex.org/C27158222","wikidata":"https://www.wikidata.org/wiki/Q5532422","display_name":"Generalizability theory","level":2,"score":0.46387091279029846},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.44417837262153625},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.4429621696472168},{"id":"https://openalex.org/C64903051","wikidata":"https://www.wikidata.org/wiki/Q2198549","display_name":"Drug development","level":3,"score":0.44194889068603516},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.37424740195274353},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.3064066767692566},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.16254302859306335},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.09369665384292603},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.08914980292320251},{"id":"https://openalex.org/C138496976","wikidata":"https://www.wikidata.org/wiki/Q175002","display_name":"Developmental psychology","level":1,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D003226","descriptor_name":"Congresses as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005434","descriptor_name":"Flow Cytometry","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009101","descriptor_name":"Multiple Myeloma","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":true},{"descriptor_ui":"D009101","descriptor_name":"Multiple Myeloma","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D009101","descriptor_name":"Multiple Myeloma","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D009101","descriptor_name":"Multiple Myeloma","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D014408","descriptor_name":"Biomarkers, Tumor","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":true},{"descriptor_ui":"D014408","descriptor_name":"Biomarkers, Tumor","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D016019","descriptor_name":"Survival Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018365","descriptor_name":"Neoplasm, Residual","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":true},{"descriptor_ui":"D018365","descriptor_name":"Neoplasm, Residual","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D018365","descriptor_name":"Neoplasm, Residual","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D018365","descriptor_name":"Neoplasm, Residual","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1002/ajh.23831","doi":"https://doi.org/10.1002/ajh.23831","is_oa":false,"landing_page_url":"https://doi.org/10.1002/ajh.23831","pdf_url":null,"source":{"id":"https://openalex.org/S199810014","display_name":"American Journal of Hematology","issn_l":"0361-8609","issn":["0361-8609","1096-8652"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-1","poland-140","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Journal of Hematology","raw_type":"journal-article"},{"id":"pmid:25132630","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25132630","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American journal of hematology","raw_type":"Letter"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":7,"referenced_works":["https://openalex.org/W1969552142","https://openalex.org/W2013357472","https://openalex.org/W2028286166","https://openalex.org/W2086595383","https://openalex.org/W2090310344","https://openalex.org/W2139260559","https://openalex.org/W2148758597"],"related_works":["https://openalex.org/W1963342145","https://openalex.org/W2508485999","https://openalex.org/W3038802153","https://openalex.org/W2918534205","https://openalex.org/W2557375821","https://openalex.org/W7165384963","https://openalex.org/W4206411872","https://openalex.org/W4405020186","https://openalex.org/W7131777817","https://openalex.org/W3215230930"],"abstract_inverted_index":{"To":[0,473],"the":[1,28,67,71,74,78,83,91,94,107,110,113,121,144,156,164,169,172,191,196,211,219,222,311,393,447,467,535,551,583,597,601,619],"Editor:":[2],"The":[3],"qualification":[4],"process":[5,18],"for":[6,38,126,130,184,210,451,460,479,504,588,603,615,689],"a":[7,12,16,44,63,181,199,230,258,264,320,352,390],"surrogate":[8,45,182,607],"endpoint":[9,37,81,116],"biomarker":[10,95,111,183],"as":[11,35,180,437,518,533,610],"development":[13,513],"tool":[14],"is":[15,86,128,414,562],"formalized":[17],"based":[19,369,547],"on":[20,76,143,171,277,351,403],"evidentiary":[21],"standards":[22],"and":[23,70,82,96,99,112,123,134,187,269,333,367,419,454,509,514,545,567,605,646,658,716],"FDA":[24,157],"requirements":[25],"exist":[26],"regarding":[27,529],"use":[29,505],"of":[30,66,73,109,120,136,148,175,193,198,213,224,238,298,313,355,364,395,469,537,542,554,585,670,714],"minimal":[31],"residual":[32],"disease":[33,68],"(MRD)":[34],"an":[36,139,571],"drug":[39,185,464],"approval.":[40],"For":[41],"regulatory":[42,461],"approval,":[43],"must":[46,59],"be":[47,50,60,427,443,458],"shown":[48],"to":[49,53,89,100,188,207,236,261,286,336,374,388,426,442,494,510,524,599],"reasonably":[51],"likely":[52],"predict":[54],"clinical":[55,79,114,173,249,507,613],"benefit":[56,80,115],"but":[57,345],"this":[58,475],"coupled":[61],"with":[62,163,226,240,254,315,339,357,376,416,429,492,564,573],"clear":[64],"understanding":[65],"process,":[69,476],"effect":[72],"intervention":[75],"both":[77],"biomarker.":[84],"It":[85],"also":[87],"important":[88],"recognize":[90],"relationship":[92,206],"between":[93],"different":[97],"interventions":[98],"identify":[101],"confounding":[102],"factors":[103],"that":[104,252,323,410,557,582],"may":[105],"diminish":[106],"correlation":[108],"1-3.":[117],"Finally,":[118],"standardization":[119,197],"definition":[122],"assessment":[124,297],"methods":[125],"MRD":[127,149,176,214,291,305,327,347,379,396,404,412,424,439,456,482,560,591],"necessary":[129],"wider":[131],"implementation,":[132],"generalizability,":[133],"interpretation":[135],"results.":[137],"Recently,":[138],"FDA-NCI":[140],"Roundtable":[141],"Symposium":[142],"flow":[145,200,295,303,325,377,480,558,589],"cytometric":[146,201,559,590],"detection":[147,212,561],"in":[150,158,177,215,392,406,446,466,506,593,612],"multiple":[151,178,216,227,255,316,340,358,452,470,594,616],"myeloma":[152,179,228,256,317,341,407,453,471,595,617],"was":[153],"held":[154],"at":[155],"Silver":[159,662],"Spring,":[160,663],"Maryland":[161],"4":[162],"goals":[165],"to:":[166],"(a)":[167],"examine":[168],"evidence":[170],"utility":[174],"response;":[186],"(b)":[189],"ascertain":[190],"status":[192,397],"consensus":[194],"concerning":[195],"device":[202],"(assay)":[203],"(and":[204],"its":[205],"molecular":[208,360,383,538],"tests)":[209],"myeloma.":[217],"Over":[218],"past":[220],"decade,":[221],"proportion":[223],"patients":[225,239,253,278,314,338,356],"achieving":[229,279],"complete":[231],"response":[232,260,449],"(CR)":[233],"has":[234,385,408,596],"risen":[235],"50\u201375%":[237],"many":[241],"reaching":[242,257],"stringent":[243],"CR":[244,280,344],"(sCR)":[245],"5.":[246],"As":[247],"expected,":[248],"studies":[250,275,421,521,569],"show":[251,284],"deeper":[259],"therapy":[262,283],"have":[263,289,329,371,422,484],"better":[265,331,417,430,565,574],"progression-free":[266],"survival":[267,271],"(PFS)":[268],"overall":[270],"(OS).":[272],"Interestingly,":[273],"recent":[274],"focusing":[276,402],"after":[281],"high-dose":[282],"up":[285],"about":[287],"30%":[288],"detectable":[290],"by":[292],"former":[293],"(standard-sensitivity)":[294],"cytometry":[296,304,326,378,481],"bone":[299],"marrow":[300],"aspirates":[301],"(i.e.,":[302],"positive)":[306],"2,":[307,433,577],"6.":[308],"Furthermore,":[309],"within":[310,618],"group":[312],"who":[318,342],"achieve":[319],"CR,":[321],"those":[322,337],"are":[324,346,490,522],"negative":[328,413],"significantly":[330],"PFS":[332,418],"OS":[334,431,575],"compared":[335],"reach":[343],"positive":[348],"7.":[349,381,435],"Based":[350],"smaller":[353],"number":[354],"myeloma,":[359],"assays":[361,539],"(e.g.,":[362,540],"sequencing":[363,541],"IgH":[365,543],"locus":[366,544],"PCR":[368,546],"assays)":[370,548],"been":[372,386,485],"reported":[373,387,409],"correlate":[375],"testing":[380,405,440,483,592],"Additionally,":[382],"imaging":[384],"play":[389],"role":[391,536],"determination":[394],"8.":[398],"Virtually":[399],"every":[400],"study":[401],"being":[411],"associated":[415,428,563],"some":[420,568],"found":[423],"negativity":[425],"1,":[432,576],"6,":[434,578],"Therefore,":[436],"proposed,":[438,519],"needs":[441],"accurately":[444],"defined":[445],"uniform":[448],"criteria":[450],"consequently,":[455],"should":[457],"considered":[459],"purposes":[462],"including":[463],"approval":[465],"field":[468],"4.":[472,487,549],"facilitate":[474],"preliminary":[477],"strategies":[478],"developed":[486],"Indeed,":[488],"efforts":[489],"ongoing":[491],"stakeholders":[493],"develop":[495],"new":[496],"International":[497],"Myeloma":[498],"Working":[499],"Group":[500],"(IMWG)":[501],"\"response":[502],"criteria\"":[503],"trials":[508,614],"agree":[511],"upon":[512],"implementation":[515],"details.":[516],"Importantly,":[517],"future":[520],"needed":[523],"further":[525],"expand":[526],"our":[527],"knowledge":[528],"optimal":[530],"antigen":[531],"panels":[532],"well":[534],"Given":[550],"consistent":[552],"body":[553],"data":[555],"showing":[556,570],"PFS,":[566],"association":[572],"7,":[579],"we":[580],"conclude":[581],"introduction":[584],"well-validated":[586],"protocols":[587],"potential":[598],"pave":[600],"way":[602],"cell-based":[604],"molecular-based":[606],"biomarkers":[608],"7":[609],"endpoints":[611],"near":[620],"future.":[621],"Ola":[622],"Landgren,1*":[623],"Nicole":[624],"Gormley,2":[625],"Danielle":[626],"Turley,2":[627],"Roger":[628],"G.":[629],"Owen,3Andy":[630],"Rawstron,3":[631],"Bruno":[632],"Paiva,4":[633],"David":[634],"Barnett,5":[635],"Maria":[636],"Arroz,6":[637],"Paul":[638],"Wallace,7Brian":[639],"Durie,8":[640],"Constance":[641],"Yuan,1":[642],"Ahmet":[643],"Dogan,9Maryalice":[644],"Stetler-Stevenson,1":[645],"Gerald":[647],"E.":[648],"Marti2":[649],"1National":[650],"Cancer":[651,711,724,733],"Institute":[652,669],"(NCI),":[653],"Bethesda,":[654],"Maryland;":[655,664],"2U.S.":[656],"Food":[657],"Drug":[659],"Administration":[660],"(FDA),":[661],"3HMDS":[665],"Laboratory,":[666],"St":[667],"James's":[668],"Oncology,":[671],"Leeds,":[672],"United":[673],"Kingdom;":[674],"4Cl\u00ednica":[675],"Universidad":[676],"de":[677,680,699],"Navarra;":[678],"Centro":[679],"Investigaci\u00f3n":[681],"M\u00e9dica":[682],"Aplicada":[683],"(CIMA),":[684],"Pamplona,":[685],"Spain;":[686],"5UK":[687],"NEQAS":[688],"Leucocyte":[690],"Immunophenotyping,":[691],"Royal":[692],"Hallamshire":[693],"Hospital,":[694],"Shefield,":[695],"England;":[696],"6Centro":[697],"Hospitalar":[698],"Lisboa":[700],"Ocidental":[701],"(CHLO),":[702],"HSFX,":[703],"Clinical":[704],"Pathology":[705],"Department,":[706],"Lisbon,":[707],"Portugal;":[708],"7Roswell":[709],"Park":[710],"Institute,":[712],"Department":[713],"Flow":[715],"Image":[717],"Cytometry,":[718],"Buffalo,":[719],"New":[720,735,737],"York;":[721],"8Cedars-Sinai":[722],"Comprehensive":[723],"Center,":[725,734],"Los":[726],"Angeles,":[727],"California;":[728],"9Hematopathology":[729],"Service,":[730],"Memorial":[731],"Sloan-Kettering":[732],"York,":[736],"York":[738]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":7},{"year":2017,"cited_by_count":12},{"year":2016,"cited_by_count":8},{"year":2015,"cited_by_count":15},{"year":2014,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}